Letter: vitamin D deficiency and autoimmune hepatitis - from research to treatment-authors' reply

Affiliations

¹ Division of Gastroenterology & Liver Unit, University of Alberta Hospital, Edmonton, Alberta, Canada.
² Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.

Comment

Maryam Ebadi et al. Aliment Pharmacol Ther. 2019 Apr.

. 2019 Apr;49(8):1104-1105.

doi: 10.1111/apt.15154.

¹ Division of Gastroenterology & Liver Unit, University of Alberta Hospital, Edmonton, Alberta, Canada.
² Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.

No abstract available

Comment on

Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis.
Ebadi M, Bhanji RA, Mazurak VC, Lytvyak E, Mason A, Czaja AJ, Montano-Loza AJ. Ebadi M, et al. Aliment Pharmacol Ther. 2019 Jan;49(2):173-182. doi: 10.1111/apt.15029. Epub 2018 Nov 28. Aliment Pharmacol Ther. 2019. PMID: 30484857
Letter: vitamin D deficiency and autoimmune hepatitis - from research to treatment.
Wang J, Xu J, Shao X, Wu Z, Liang C. Wang J, et al. Aliment Pharmacol Ther. 2019 Apr;49(8):1103. doi: 10.1111/apt.15147. Aliment Pharmacol Ther. 2019. PMID: 30920038 No abstract available.